Skip to main content
Clinical Trials/IRCT20200504047298N2
IRCT20200504047298N2RecruitingPhase 3

Effect of Opontia Cactus extract on improving pulmonary and clinical function in patients with Covid-19

Karaj University of Medical Sciences0 sites48 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
48

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Patients who have CT scan or PCR data in accordance with Covid-19
  • Patients aged 18 to 60 years
  • Patients who have not hypoxemia (oxygen saturation more than 90%)

Exclusion Criteria

  • Patients who taking herbal supplements are excluded
  • Patients who were receiving mechanical ventilation or extracorporeal membrane oxygenation (ECMO) ? are excluded
  • Patients with signs of multiorgan failure at screening (Exclusion criteria included alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels greater than 5 times the upper limit of the normal range or estimated creatinine clearance of less than 50 ml per minute (by the Cockcroft–Gault formula)) are excluded

Investigators

Sponsor
Karaj University of Medical Sciences

Similar Trials